Danielle Vrabie is an associate in the Business Trial Practice Group in the firm’s New York office and a member of the firm’s healthcare practice team.
Areas of Practice
Danielle represents corporate clients and individuals in complex commercial litigation and government investigations throughout the country. A substantial portion of Danielle’s practice is dedicated to serving healthcare and life sciences clients, including hospitals and health systems, physician and specialty practice groups, managed care organizations, pharmaceutical companies, long-term care providers, and medical device companies. She has experience representing these clients in a variety of contexts, including commercial disputes and litigation, enforcement actions, government investigations, state Medicaid audits, repayment demands, and voluntary self-disclosures. She also has significant experience defending against investigations and litigation involving allegations under the False Claims Act, Stark Law, Anti-Kickback Statute, and similar anti-fraud statutes. In this context, she also assists companies in conducting internal investigations regarding fraud, allegations of employee misconduct, and whistleblower complaints and developing cost-effective and practical compliance and risk management programs.
Danielle helped establish and co-leads the firm’s Women in Healthcare Leadership Collaborative, whose goal is to promote the advancement of women in the healthcare industry by bringing them together in a supportive community and providing them with targeted education focused on complex legal issues, healthcare innovation, and other critical issues.
Danielle’s general litigation practice includes representing clients in the financial services, aerospace, technology, and manufacturing industries in cases involving breach of contract, fraud, trade secrets, non-competition and non-solicitation agreements, trade libel, and allegations of unfair trade practices.
Danielle also maintains an active pro bono practice. She has been recognized for three consecutive years by The Legal Aid Society for her outstanding pro bono service. Danielle recently obtained a directed verdict following a bench trial in New York Supreme Court, New York County for her client who was accused of operating a children’s dance studio in violation of her lease.
While in law school, Danielle was named an Alexander Fellow, allowing her the opportunity to serve as a student judicial clerk to the Honorable Kimba M. Wood, Chief Judge of the Southern District of New York. She also served as a judicial intern to the Honorable Dora L. Irizarry in the Eastern District of New York. In 2020, Danielle was honored with the firm's third annual Bob Williams Award, which recognizes Sheppard Mullin attorneys and staff who provide exceptional service for the betterment of the firm and the community.
False Claims Act
- Representation of home health provider in False Claims Act suit related to allegations of non-compliance with CMS regulations.
- Representation of medical equipment supplier in qui tam suit filed by former employee alleging violations of CMS guidelines governing DME suppliers purportedly resulting in submission of false claims.
- Representation of medical director physicians accused of upcoding and providing medically unnecessary services.
- Representation of leading aerospace manufacturing company in False Claims Act suit relating to parts certification for airplanes flown by the Department of Defense; district court dismissed all claims pre-discovery and decision was affirmed on appeal.
Internal Investigations & Government Investigations
- Representation of multiple physician practices in connection with DOJ investigation into clinical laboratory arrangements.
- Representation of pharmaceutical company in DOJ investigation concerning allegations of kickbacks to physicians.
Complex Commercial Litigation
- Representation of medical device company in connection with breach of contract claim against private equity firm regarding exercise of certain stock rights.
- Representation of global healthcare company in Federal suit and arbitration proceedings in which former employees sought change-in-control benefits exceeding $15 million.
- Representation of leading aerospace manufacturing company in trade secrets misappropriation suit against former employee who secretly agreed to join direct competitor.
Pro Bono Publico Award, Legal Aid Society, 2013-2015
- Law360, 03.04.2019
- Co-author of the “Health Care Fraud and Abuse 2016 Update” chapter in Health Law Handbook, Twenty-Ninth Edition (2017), WestGroup, a Thomson Company.
- Co-author of the “Excuses Doctrine” chapter in Commercial Contracts: Strategies for Drafting and Negotiating, Second Edition (2015), Wolters Kluwer.
Coronavirus Oversight and Enforcement Posts
- "Big Data: The Next Frontier In Cares Act Fraud Detection," September 15, 2020
Government Contracts, Investigations & International Trade Blog Posts
- "Kickbacks Aren’t Illegal Just for Federal Health Care Programs in Recently Enacted SUPPORT Act: New Compliance Concerns for Physician-Owned Laboratories," November 6, 2018
Healthcare Law Blog Posts
- "Compliance Risk Alert: Opioid Warning Letters issued by the U.S. Department of Justice Target Prescribers," February 6, 2019
Finance & Bankruptcy Law Blog Posts
- Moderator, "Ethically Handling FCA Investigations, Litigation, and Whistleblowers," False Claims Act and Qui Tam Trial Institute 2019, June 19, 2019
- 2020 Healthcare Policy, Legal and Regulatory Predictions, Sheppard Mullin, New York and Sheppard Mullin, San Francisco, 01.23.2020
J.D., Benjamin Cardozo Law School, Yeshiva University, 2009
B.S., The College of New Jersey, 2006, magna cum laude
- New York
- U.S. District Court for the Southern and Eastern Districts of New York
- U.S. Court of Appeals, Fifth Circuit